A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4⁺ T Cells

Supplemental material

• Supplemental file 1 -

  Fig. S1 (CpG2006 induces IFN-α, IL-2, and TNF-α.)

  Fig. S2 (CpG2006 activates NK cells.)

  Fig. S3 (MGN1703 does not affect NK cell receptors on CD56_bright and CD56_neg NK cells.)

  Fig. S4 (CpG2006 and LPS does not affect NK cell receptors on NK cells.)

  Fig. S5 (Panobinostat does not alter TLR9-induced functions.)

  PDF, 3.4M